Healthy Directions, LLC   Report issue

For profit Phase 1
Founded: Bethesda MD United States (1974)
Status: No NME R&D (1974)

Organization Overview

First Clinical Trial
2015
NCT02415114
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (2)

resveratrol (1 trial)

ubiquinone (1 trial)

Drugs in Other Trials (1)

berberine (1 trial)

Indications

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 3